Early Minimal Residual Disease (MRD) Analysis During Treatment of Philadelphia Chromosome / Bcr -Abl Positive Acute Lymphoblastic Leukemia (Ph + ALL) with the Abl -Tyrosine Kinase Inhibitor STI571 (Glivec) Running title: MRD Analysis in Ph + ALL During STI571 T reatment

2002 
    • Correction
    • Cite
    • Save
    • Machine Reading By IdeaReader
    29
    References
    0
    Citations
    NaN
    KQI
    []